As one of the first international law firms to establish a dedicated healthcare practice, we have advised US healthcare organizations for more than 85 years—beginning with our legacy firm’s foundational role in establishing the Texas Medical Center in Houston in 1941. Our Healthcare team is ranked as a leading law firm at the state and national level by Chambers USA and has continuously been recognized with the American Health Law Association’s Top Honors award for excellence in health law, including in 2026.
Our firm’s international platform also enables us to advise multijurisdictional health systems and cross-border private equity sponsors on healthcare transactions and regulatory compliance matters spanning multiple jurisdictions.
Contacts
secondary
Common questions answered
Who does Norton Rose Fulbright's healthcare law practice represent?
Norton Rose Fulbright's US Healthcare practice represents leading hospitals and health systems, private equity sponsors and non-profit healthcare organizations—including large, small and rural hospital systems, community and freestanding pediatric hospitals, multi-specialty clinics and academic medical centers encompassing medical schools, research institutes and healthcare innovation centers—as well as multispecialty physician groups, ancillary medical providers, non-profit healthcare organizations and ambulatory surgery centers.
Our Healthcare team is active in advising clients concerning complex joint venture arrangements and other corporate transactional matters, healthcare antitrust issues, enforcement and litigation, Medicare and Medicaid reimbursement, state and federal healthcare regulatory compliance, Health Insurance Portability and Accountability Act (HIPAA) considerations, commercial and governmental managed care, clinical research and grants compliance issues , graduate medical education (GME), medical staff matters and artificial intelligence (AI) governance.
What healthcare transactional services does Norton Rose Fulbright provide?
Norton Rose Fulbright advises on health system mergers, hospital acquisitions, physician group acquisitions and other complex healthcare mergers and acquisitions (M&A), as well as joint ventures, member substitutions, strategic affiliations, collaborations, private equity investments, financing and other complex healthcare transactions.
Our lawyers guide clients from diligence through implementation, with a focus on regulatory compliance, tax-exempt considerations, corporate governance, financing structures and antitrust risk.
What healthcare antitrust services does Norton Rose Fulbright provide?
Norton Rose Fulbright advises hospitals, health systems, physician groups and private equity sponsors on the full range of healthcare antitrust issues, including Hart-Scott-Rodino (HSR) filing requirements, merger clearance strategy, Federal Trade Commission (FTC) and Department of Justice (DOJ) investigations, and pre-transaction competitive analysis.
Our team counsels clients on antitrust risk in health system mergers, hospital acquisitions, physician group consolidations, joint ventures and clinically integrated networks. We also advise on price-fixing, market allocation and other conduct issues arising under federal and state antitrust law, helping healthcare organizations structure transactions and collaborative arrangements to withstand regulatory scrutiny.
How does Norton Rose Fulbright defend healthcare clients in state and federal healthcare enforcement actions and litigation?
Norton Rose Fulbright’s Healthcare lawyers manage compliance programs, provide risk assessments, counsel concerning the development and implementation of internal investigations, self-disclosures and government inquiries involving the False Claims Act (FCA), Stark Law, Anti-Kickback Statute (AKS). This representation also includes coding and billing issues involving Medicare, Medicaid, and other state and federal healthcare programs.
We frequently defend clients in investigations involving the US Department of Justice (DOJ), US Department of Health and Human Services (HHS), the Centers for Medicare and Medicaid Services (CMS) and state regulators including states attorneys general. In litigation, we defend providers against subpoenas, civil investigative demands, whistleblower claims and enforcement actions, drawing on deep experience navigating the intersection of regulatory exposure and reputational risk.
How does Norton Rose Fulbright handle Medicare, Medicaid, managed care and payor reimbursement disputes?
Norton Rose Fulbright’s Healthcare team helps providers resolve Medicare, Medicaid and commercial payor disputes—including audits, appeals, overpayments, 340B Drug Pricing Program issues, denied or underpaid claims, No Surprises Act litigation and reimbursement recovery strategies.
We structure and negotiate managed care contracts, Medicare Advantage arrangements, Medicaid managed care agreements and Centers for Medicare and Medicaid Services (CMS) Innovation Center models, including the Accountable Care Organization Realizing Equity, Access, and Community Health (ACO Reach) model. Our Healthcare lawyers advise on Accountable Care Organizations (ACOs), Patient-Centered Medical Homes (PCMHs), Clinically Integrated Networks (CINs) and other value-based care arrangements, helping providers address payment terms, quality metrics, payor denials, underpayments, billing disputes and reimbursement conflicts.
We also advise on the regulatory and contractual dimensions of telehealth and telemedicine programs including platform compliance, licensure across state lines, payor coverage policies, reimbursement for virtual care services and the integration of telehealth arrangements into managed care contracts and value-based care models.
What hospital operations, licensure and medical staff services does Norton Rose Fulbright offer?
Norton Rose Fulbright advises hospitals and health systems on the full range of operational, licensure and medical staff matters critical to institutional risk management and patient care. Our counsel covers credentialing, privacy compliance, emergency preparedness, the Emergency Medical Treatment and Labor Act (EMTALA), Joint Commission standards, bylaws, peer review, employment issues, vendor management, revenue strategies, physician contracting and related disputes.
Our lawyers support healthcare organizations on both day-to-day operational needs and governance matters that affect long-term institutional stability.
How does Norton Rose Fulbright advise on clinical trials, healthcare research and graduate medical education?
Norton Rose Fulbright advises academic medical centers, hospitals, clinical research organizations (CROs), other clinical research sites and sponsors on Food and Drug Administration (FDA) regulations governing investigational new drugs and medical device clinical studies and trials, HHS Office for Human Research Protections (OHRP) human subjects protection regulations and requirements, the Common Rule, good clinical practice (GCP) standards, scientific integrity, research misconduct and broader research compliance matters. We also prepare and negotiate clinical trial agreements, investigator-initiated study agreements, collaboration agreements, data use agreements and data transfer agreements that support innovation while managing regulatory and operational risk.
On GME, Norton Rose Fulbright advises medical schools, academic medical centers, health systems and teaching hospitals on Accreditation Council for Graduate Medical Education (ACGME) matters, including by counseling Sponsoring Institutions and GME programs on ACGME requirements and advising Sponsoring Institutions and GME programs that may be the subject of adverse ACGME actions. Norton Rose Fulbright further advises on Liaison Committee on Medical Education (LCME) accreditation, Medicare GME reimbursement, GME Affiliated Group Agreements, Commission on Dental Accreditation (CODA), Council on Podiatric Medical Education (CPME)-accredited residencies and National Resident Matching Program (NRMP) matters. We also structure academic affiliation agreements, new medical campus transactions, faculty practice plans, pediatric hospital joint ventures and integrations involving community physicians, hospital-sponsored medical groups and other independent medical groups.
How does Norton Rose Fulbright advise on HIPAA compliance, data breaches and healthcare cybersecurity?
Norton Rose Fulbright advises healthcare organizations on compliance with HIPAA and the Health Information Technology for Economic and Clinical Health Act (HITECH), data breach response, Office for Civil Rights (OCR) investigations, cybersecurity risk management, cyber incident response planning, breach preparedness, privacy compliance frameworks and healthcare-specific cybersecurity regulation.
As ransomware attacks, third-party vendor breaches and state-sponsored cyber threats against hospitals and health systems have intensified, we advise clients on pre-incident preparedness—including tabletop exercises, vendor security due diligence and security risk analysis—as well as post-incident response, regulatory notification obligations, OCR enforcement defense and litigation defense arising from healthcare data breaches.
Our work in this area supports hospitals, health systems and healthcare technology providers facing the evolving intersection of privacy, security and digital health risk—an area of growing enforcement priority for regulators.
Market recognitions
24
Related services
secondary
true
true
secondary
true
true